Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30043792HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043793HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043794HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043795HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043796HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043797HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043798HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043799HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043800HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TVIS30043801HIVENSG00000131747.15protein_codingTOP2AYesNo7153P11388
TCGA Plot Options
Drug Information
GeneTOP2A
DrugBank IDDB00694
Drug NameDaunorubicin
Target IDBE0000742
UniProt IDP11388
Regulation Typeinhibitor
PubMed IDs6380596; 1963303
CitationsAubel-Sadron G, Londos-Gagliardi D: Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review. Biochimie. 1984 May;66(5):333-52.@@Zunino F, Capranico G: DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des. 1990 Nov;5(4):307-17.
GroupsApproved
Direct ClassificationAnthracyclines
SMILESCOC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O
Pathways
PharmGKBPA449212
ChEMBLCHEMBL178